Team:UNIPV-Pavia/Debug
From 2009.igem.org
(Difference between revisions)
(2 intermediate revisions not shown) | |||
Line 9: | Line 9: | ||
</html> | </html> | ||
- | <table width="100%" border=" | + | <table width="100%" border="0"> |
<tr> | <tr> | ||
<td valign="top" width= "19%" rowspan="2"> | <td valign="top" width= "19%" rowspan="2"> | ||
Line 40: | Line 40: | ||
<html><!-- Qui ho tolto il titolo--></html> | <html><!-- Qui ho tolto il titolo--></html> | ||
- | During this summer, we sequenced and carefully analyzed sequencing results of some existing BioBrick parts. Some of them were not present in DNA Distribution | + | During this summer, we sequenced and carefully analyzed sequencing results of some existing BioBrick parts. Some of them were not present in DNA Distribution, so they have been sent us by iGEM Headquarters. |
=====BBa_T9002===== | =====BBa_T9002===== | ||
- | <partinfo>BBa_T9002</partinfo>: The UNIPV-Pavia iGEM team sequenced this part and found that it was completely confirmed, while iGEM QC | + | <partinfo>BBa_T9002</partinfo>: The UNIPV-Pavia iGEM team sequenced this part and found that it was completely confirmed, while iGEM QC 2009 DNA distribution classified it as "inconsistent". DNA was resuspended from well 9A, kit plate 2, transformed in TOP10 E. coli and amplified inoculating a single colony from the grown LB agar plate in LB medium. Finally DNA has been miniprepped from the grown culture and sent to a BMR Genomics (Padova, Italy) for sequencing. |
<div align="right"> | <div align="right"> | ||
Line 50: | Line 50: | ||
=====BBa_K131009===== | =====BBa_K131009===== | ||
- | <partinfo>BBa_K131009</partinfo>: After the alignment of this BioBrick sequence from | + | <partinfo>BBa_K131009</partinfo>: After the alignment of this BioBrick sequence from Quality Control with the theoretical sequence, some difformities have been reported (sequencing results have been taken from iGEM QC): i) there is a non-silent point mutation in nucleotide 2142 which changes an amino acid of celB gene; ii) non-standard prefix (even if all the restriction sites are correct); iii) non-standard suffix (even if all the restriction sites are correct). |
<div align="right"> | <div align="right"> | ||
Line 64: | Line 64: | ||
=====BBa_K116001===== | =====BBa_K116001===== | ||
- | <partinfo>BBa_K116001</partinfo>: The UNIPV-Pavia iGEM 2009 team requested this part from iGEM Headquarters, but sequence was not correct: actually, the part contained in the plasmid was BBa_K116002 and it also has an additional undocumented "c" nucleotide at the end of nhaA promoter (found after sequencing). | + | <partinfo>BBa_K116001</partinfo>: The UNIPV-Pavia iGEM 2009 team requested this part from iGEM Headquarters, but sequence was not correct: actually, the part contained in the plasmid was BBa_K116002 and it also has an additional undocumented "c" nucleotide at the end of nhaA promoter (found after sequencing). Because BBa_K116002 is the measurement system of K116001 BioBrick, we used it to characterize the activity of nhaA promoter. |
- | + | ||
- | Because BBa_K116002 is the measurement system of | + | |
<div align="right"> | <div align="right"> | ||
Line 101: | Line 99: | ||
=====BBa_I746902===== | =====BBa_I746902===== | ||
- | <partinfo>BBa_I746902</partinfo>: This part was not present in 2009 DNA Distribution and no quality control had been performed. The UNIPV-Pavia requested this part to iGEM Headquarters, sequenced it and found that sequence was correct ( | + | <partinfo>BBa_I746902</partinfo>: This part was not present in 2009 DNA Distribution and no quality control had been performed. The UNIPV-Pavia requested this part to iGEM Headquarters, sequenced it and found that the covered part of the sequence was correct (almost all the sequence was covered). |
<div align="right"> | <div align="right"> | ||
Line 115: | Line 113: | ||
=====BBa_K112808===== | =====BBa_K112808===== | ||
- | <partinfo>BBa_K112808</partinfo>: After the alignment of this BioBrick sequence from 2009 DNA Distribution with the theoretical sequence, many difformities have been reported (sequencing results have been taken from iGEM QC): i) the alignment showed several gaps in the scars; ii) there is a silent point mutation in holin gene; iii) the transcriptional terminator at the end of the sequence is actually K112710, not B0010. | + | <partinfo>BBa_K112808</partinfo>: After the alignment of this BioBrick sequence from 2009 DNA Distribution with the theoretical sequence, many difformities have been reported (sequencing results have been taken from iGEM QC): i) the alignment showed several gaps in the scars; ii) there is a silent point mutation in holin gene; iii) the transcriptional terminator at the end of the sequence is actually K112710, not B0010. However, the part should work properly because the regulatory parts and the amino acid sequence of the genes are correct. This has also been confirmed by functional tests. |
- | + | ||
- | However, the part should work properly because the regulatory parts and the amino acid sequence of the genes are correct. This has also been confirmed by functional tests | + | |
<div align="right"> | <div align="right"> | ||
Line 129: | Line 125: | ||
[[#top|Top]] | [[#top|Top]] | ||
</div> | </div> | ||
+ | |||
+ | <b> All these comments are also reported in the Experience pages of the relative BioBrick parts in the Registry web site.</b> | ||
<html> | <html> |
Latest revision as of 16:14, 21 October 2009
|
Existing parts: debug |
|
Re-built existing parts (BBa_our part code/BBa_existing part code) Existing parts from the Registry Existing parts sequence debugging:
During this summer, we sequenced and carefully analyzed sequencing results of some existing BioBrick parts. Some of them were not present in DNA Distribution, so they have been sent us by iGEM Headquarters. BBa_T9002
BBa_K131009
BBa_K131010
BBa_K116001
BBa_K116002
BBa_P0412
BBa_K112405
BBa_K101017
BBa_I746902
BBa_I746903
BBa_K112808
BBa_F2620
All these comments are also reported in the Experience pages of the relative BioBrick parts in the Registry web site.
|